Plentywood Drug Inc.

Community/Retail Pharmacy Accepts Medicare



  
  119 N Main St, Plentywood
Montana, 59254-1817

 406-765-1810   
Plentywood Drug Inc. is a Community/Retail Pharmacy in Plentywood, Montana. It is located at 119 N Main St, Plentywood and it's customer support contact number is 406-765-1810. The authorized person of Plentywood Drug Inc. is Mr. Marvin A Eberling, R.PH who is Owner of the pharmacy and his contact number is 406-765-1810. Active license number of Plentywood Drug Inc. is 984 for Community/Retail Pharmacy in Montana. Plentywood Drug Inc. accepts medicare which means medicare covered patients will not be billed for any more than the Medicare deductible and coinsurance.
Plentywood Drug Inc. is a pharmacy where pharmacists store, prepare, and dispense medicinal preparations and/or prescriptions for a local patient population in accordance with federal and state law; counsel patients and caregivers (sometimes independent of the dispensing process); administer vaccinations; and provide other professional services associated with pharmaceutical care such as health screenings, consultative services with other health care providers, collaborative practice, disease state management, and education classes.


Pharmacy Details:
Plentywood Drug Inc. type, location, contact phone number and fax are as below. Patients can directly walkin to the pharmacy or can call on the below given customer support phone number for enquiries.
Name: Plentywood Drug Inc.
Type: Community/Retail Pharmacy
Location:119 N Main St, Plentywood,
Montana, 59254-1817
Phone:406-765-1810
Authorized/Official Person Profile:
Officially authorized person to contact for any management issues or complaints of this pharmacy is as below. Person's position and contact details are also mentioned below.
Name: Mr. Marvin A Eberling
Credentials: R.PH
Position: Owner
Contact Number: 406-765-1810
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of given pharmacy are as mentioned below.
NPI Number: 1073514428
NPI Enumeration Date: 09 Aug, 2005
NPI Last Update On: 21 Jan, 2016

Medical Licenses:
Organizations can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Plentywood Drug Inc. are as mentioned below.
SpecializationLicense NumberStateStatus
Community/Retail Pharmacy 984MontanaPrimary
Long Term Care Pharmacy 984MontanaSecondary
Durable Medical Equipment & Medical Supplies 984MontanaSecondary
Parenteral & Enteral Nutrition 984MontanaSecondary
Other Medical Identifiers:
Other legacy medical identifiers of the pharmacy such as Medicaid, Medicare PIN, NSC, UPIN etc. are mentioned as below.
IdentifierTypeStateIssuer
219219MedicaidMontana
1073514428OtherMontanaMedicare
Medicare Enrollment:
Plentywood Drug Inc. is enrolled in medicare and it's Pac Id, enrollment Id, registered name and type is as stated below.
PAC ID: Enrollment ID: Org NameMedicare Entity Type
9931225513O20100930088077Plentywood Drug IncDME SUPPLIER - PHARMACY
Products Available:
Plentywood Drug Inc. has following products available for sale under medicare.
Products
•  Blood Glucose Monitors & Supplies: Non-mail Order•  Walkers
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: 119 N Main St,
Plentywood, Montana
Zip: 59254-1817
Phone Number: 406-765-1810
Fax Number: --
Patients can reach Plentywood Drug Inc. at 119 N Main St, Plentywood, Montana or can call on customer care at 406-765-1810.
Comments/ Reviews:
Read all the reviews posted for Plentywood Drug Inc. below. You may also share your own experience with Plentywood Drug Inc.. Your feedback can help others make better decisions.
**Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 13 October, 2025.